| Literature DB >> 18562806 |
Anna Ahn1, William H Frishman, Andrew Gutwein, Jonathan Passeri, Michael Nelson.
Abstract
Angiogenesis is the biologic process of forming new blood vessels and is being investigated as an innovative therapeutic approach to help manage ischemic heart disease and peripheral vascular disease. Research studies have identified various angiogenic growth factors and progenitor cells that can enhance new blood vessel formation. Preclinical investigations in animal models have explored the potential use of growth factors with and without progenitor cells to treat myocardial ischemia. The results of clinical trials with growth factor infusions and gene therapy techniques to enhance growth factor production have shown some promise, but therapeutic angiogenesis remains at an early stage of development.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18562806 DOI: 10.1097/CRD.0b013e3181620e3b
Source DB: PubMed Journal: Cardiol Rev ISSN: 1061-5377 Impact factor: 2.644